Lymphoma Research Foundation
Based in NY
AI Overview
With $0 in lobbying spend across 32 quarterly filings, Lymphoma Research Foundation is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $0 |
| 2019 | $0 |
| 2020 | $0 |
| 2021 | $0 |
| 2022 | $0 |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Lymphoma Research Foundation disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED
Legislation to improve quality of care for cancer survivors, under development by Representative Debbie Wasserman Schultz
Development of cancer survivorship legislation to be introduced by Representative Wasserman Schultz.
Advice on the structure and financing of the Advanced Research Projects Agency for Health (ARPA-H).
Provide information as requested related to cancer survivorship legislation being developed by Representative Wasserman Schultz.
Cancer Survivorship legislation under development by Representative Wasserman Schultz Standards for distribution and use of monoclonal antibodies and antiviral treatments for the immune compromised
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.